Cambridge boutique McNeill Baur's catalog of patent services includes enforcement, prosecution, portfolio strategy and management, and licensing agreements. A healthcare client praises the firm for its patent prosecution skill, calling the firm's "approach to IP in a competitive biotechnology-based setting excellent, very proactive, organized, and thoughtful."
Firm co-founder Rebecca McNeill is an experienced patent prosecutor and portfolio manager, and has recently been engaged in the strategic use of an IPR to defend a biotechnology client against a potentially costly litigation, after the company received a patent infringement warning letter from a competitor. A client calls her "smart, proactive, and communicative." Georgia-based Mary Henninger provided two key freedom to operate analyses on behalf of a pharmaceutical client, helping them move away from a risky licensing deal with one party, and avoiding potential litigation with a competitor. Pennsylvania-based Amelia Feulner Baur handles the patent prosecution, strategy, counseling, freedom-to-operate, and transactional agreements on behalf of a large, publicly-traded company's gene therapy patent portfolio. She also assists a major healthcare industry player in similar matters, managing a portfolio of patents relating to the prevention of various viral infections. A client speaks glowingly of her work in patent prosecution and due diligence: "I trust Amelia to give my work the attention and effort needed while working within our budget and timeframes. They are pragmatic and knowledgeable, and able to provide helpful and accurate advice."
|Choate Hall & Stewart|
|Fish & Richardson|
|Foley & Lardner|
|Lando & Anastasi|
|McCarter & English|
|McDermott Will & Emery|
|Wolf Greenfield & Sacks|
|Finnegan Henderson Farabow Garrett & Dunner|
|GTC Law Group|
|Mintz Levin Cohn Ferris Glovsky and Popeo|
|Nelson Mullins Riley & Scarborough|
|Nutter McClennen & Fish|
|Ropes & Gray|